A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

NCT00117117 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2423
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen